Ivermectin inhibits ER, HER2, and TGF-β pathways in ER-positive and endocrine-resistant breast cancer cells

• Kitiya Rujimongkon,

  Roles Conceptualization, Formal analysis, Investigation, Methodology, Writing – original draft

  Affiliation Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

  https://orcid.org/0000-0002-6020-1619

  ⨯
• Patthamapon Adchariyasakulchai,

  Roles Methodology

  Affiliation Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

  ⨯
• Chanoknun Boonyaratsewee,

  Roles Investigation

  Affiliation Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, Thailand

  ⨯
• Kantasorn Horpratraporn,

  Roles Investigation

  Affiliation Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

  ⨯
• Wannarasmi Ketchart

  Roles Conceptualization, Formal analysis, Funding acquisition, Methodology, Writing – original draft, Writing – review & editing

  * E-mail: wannarasmi.k@chula.ac.th

  Affiliation Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

  https://orcid.org/0000-0002-1215-5750

  ⨯